Counting Coup: Is Osiris Therapeutics Losing Faith In Its Stem Cell Drug Prochymal?

In his Q2 2013 earnings call Monday, Osiris Therapeutics' CEO, C. Randal Mills, set a new company record...and probably didn't even realize it.

http://seekingalpha.com/article/1612022-counting-coup-is-osiris-therapeutics-losing-faith-in-its-stem-cell-drug-prochymal?source=feed